Cargando…
Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer
Due to the lack of typical symptoms and signs and sensitive indicators for early diagnosis of obstructive colorectal cancer (OCRC), it is critically needed to find new novel biomarkers to ameliorate the management of OCRC patients. In this study, 472 blood samples were collected and measured by enzy...
Autores principales: | Li, Longhai, Zhang, Lihua, Zhang, Ting, Qi, Xiaowei, Cheng, Gang, Xia, Lingxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902867/ https://www.ncbi.nlm.nih.gov/pubmed/33643903 http://dx.doi.org/10.3389/fonc.2020.599363 |
Ejemplares similares
-
Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer
por: Li, Longhai, et al.
Publicado: (2019) -
The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients
por: Li, Longhai, et al.
Publicado: (2021) -
Clinical and Prognostic Relevance of B7-H3 and Indicators of Glucose Metabolism in Colorectal Cancer
por: Zhang, Ting, et al.
Publicado: (2020) -
The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
por: Zhang, Xu, et al.
Publicado: (2023) -
CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer
por: Zajkowska, Monika, et al.
Publicado: (2023)